Axa’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-28,824
| Closed | -$2.01M | – | 1235 |
|
|
2022
Q3 | $2.01M | Buy |
28,824
+135
| +0.5% | +$9.43K | 0.01% | 757 |
|
|
2022
Q2 | $1.93M | Sell |
28,689
-551
| -2% | -$37K | 0.01% | 782 |
|
|
2022
Q1 | $2.4M | Sell |
29,240
-1
| -0% | -$82 | 0.01% | 798 |
|
|
2021
Q4 | $4.29M | Buy |
29,241
+347
| +1% | +$50.9K | 0.01% | 699 |
|
|
2021
Q3 | $5.11M | Buy |
28,894
+1,073
| +4% | +$190K | 0.01% | 675 |
|
|
2021
Q2 | $4.49M | Sell |
27,821
-2,110
| -7% | -$341K | 0.01% | 736 |
|
|
2021
Q1 | $5.13M | Sell |
29,931
-3,752
| -11% | -$643K | 0.02% | 703 |
|
|
2020
Q4 | $7.4M | Buy |
33,683
+1,182
| +4% | +$260K | 0.02% | 597 |
|
|
2020
Q3 | $5.4M | Sell |
32,501
-302
| -0.9% | -$50.1K | 0.02% | 600 |
|
|
2020
Q2 | $3.75M | Buy |
32,803
+5,571
| +20% | +$636K | 0.01% | 697 |
|
|
2020
Q1 | $2.09M | Sell |
27,232
-1,819
| -6% | -$140K | 0.01% | 724 |
|
|
2019
Q4 | $3.74M | Buy |
29,051
+724
| +3% | +$93.3K | 0.02% | 690 |
|
|
2019
Q3 | $2.21M | Sell |
28,327
-43
| -0.2% | -$3.35K | 0.01% | 847 |
|
|
2019
Q2 | $2.92M | Buy |
+28,370
| New | +$2.92M | 0.01% | 788 |
|